Christopher Marshall, MD
Gastroenterology · Worcester, MANPI 1942306261
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $8,243 of the $13,595 with a category attached, or 60.6%. 19 manufacturers reported payments, led by Olympus Corporation at 26.5% of the total. 2025 is the largest year on record at $3,699, 3.2 times the $1,148 reported in 2019.
Across 57 payments — averaging $238.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Olympus Corporation$4K
- Olympus Medical Systems Corporation$4K
- Medtronic$2K
- Olympus America Inc.$2K
- Boston Scientific$1K
- E.r. Squibb & Sons, L.L.C.$300
- plus $1K from 13 others
Across 77 payments — averaging $1869.62 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$57K
- Bristol Myers Squibb$38K
- Sanofi$23K
- Olympus Corporation Of The Americas$17K
- AbbVie$8K
What the payments were for
- Consulting fees$8,24361%
- Speaking & faculty fees$2,79021%
- Travel & lodging$200%
- Food & beverage$2,54219%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Olympus Corporation | 4 | $3,605 |
| Olympus Medical Systems Corporation | 2 | $3,565 |
| Medtronic | 4 | $1,840 |
| Olympus America Inc. | 3 | $1,823 |
| Boston Scientific | 20 | $1,343 |
| E.r. Squibb & Sons, L.L.C. | 1 | $300 |
| Fujifilm Healthcare Americas Corporation | 5 | $295 |
| ERBE USA Inc | 2 | $194 |
| Cook Medical LLC | 2 | $102 |
| Sanofi | 1 | $86 |
| Janssen Scientific Affairs, LLC | 2 | $76 |
| Apollo Endosurgery US Inc | 2 | $72 |
| Regeneron Healthcare Solutions, Inc. | 1 | $71 |
| AbbVie | 3 | $62 |
| Aimmune Therapeutics, Inc. | 1 | $45 |
| Johnson & Johnson | 1 | $40 |
| Mahana Therapeutics, Inc. | 1 | $33 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $26 |
| Pfizer | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GASTROINTESTINAL VIDEOSCOPE$2,065
- EndoClot SIS$1,803
- HANAROSTENT Biliary (NNN)$1,500
- FUJIFILM$269
- AXIOS$246
- EXALT Model D$210
- SPYGLASS$102
How this compares
$13,595 in reported general payments places this provider in the 85th percentile of 579 gastroenterology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XifaxanRifaximin | 11 | $34,855 |
| LinzessLinaclotide | 17 | $13,848 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 48 | $2,965 |
| Pantoprazole Sodium | 102 | $2,048 |
| Omeprazole | 96 | $1,932 |
| Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl | 88 | $1,522 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 77 | $1,126 |
| Sucralfate | 11 | $726 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 15 | $260 |
| Famotidine | 20 | $215 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $26 | $34,85511 claims |
| AbbVieLinzess | $62 | $13,84817 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 579 gastroenterology providers in Massachusetts.
Other gastroenterology in Worcester
- Benjamin HyattWorcester$135K
- Neil MaryaWorcester$127K
- Curuchi AnandWorcester$117K
- Abbas RupawalaWorcester$74K
- Gustavo ChurrangoWorcester$51K
- Anita KrishnaraoWorcester$40K
- Hiroyuki AiharaBoston$728K
- Jessica AllegrettiBoston$696K
- John LeungBoston$682K
- Ramnik XavierBoston$567K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.